NCT01688336 2017-10-06FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic CancerUNC Lineberger Comprehensive Cancer CenterPhase 2 Terminated9 enrolled 14 charts
NCT02243007 2017-05-16Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic CancerMassachusetts General HospitalPhase 2 Terminated7 enrolled 8 charts